
Week 1
Baseline

Bimatoprost Ophthalmic Solution
How Subscribe & Save works
Consultation Included
This is a prescription-strength product. Your order includes a free medical consultation with one of our licensed providers.
How it works:
If our providers determine this treatment isn't appropriate for you, your card authorization is released — you're never charged.
Reported faster lash growth in 8 weeks
Improved lash density and fullness
Increase in length, fullness, and pigmentation
Average time to visible results
* Per Allergan-sponsored clinical trial. See latisse.com/PI for full prescribing information.
HOW IT WORKS
Skip the waiting room. Tell us about your goals, get evaluated by a licensed provider, and—if appropriate—your prescription ships free.
Answer a few questions about your eyes and medical history.
A U.S.-licensed provider reviews your information within 24 hours.
If prescribed, Latisse arrives discreetly—often within 2 days.
One drop, one lash line, every evening. Results begin in ~4 weeks.

ABOUT THE TREATMENT
Latisse is a prescription medicine used to grow eyelashes, making them longer, thicker, and darker. It contains bimatoprost 0.03%, the only FDA-approved active ingredient for treating hypotrichosis—inadequate or not enough lashes.
It's applied once daily to the upper lash line using a sterile, single-use applicator. Most people see fuller lashes by week 8, with full results visible at week 16.
Extends growth phase
Bimatoprost extends the anagen — active growth — phase of each follicle.
Clinically proven*
Demonstrated efficacy in published trials.
Triple effect
Lashes grow longer, fuller, and darker over time.
Physician prescribed
Only available through a licensed provider. We make sure it's right for you.
HOW TO APPLY
STEP 01
Remove makeup and contact lenses; pat the upper lash line dry.
STEP 02
Place one drop on a single applicator. Use a fresh applicator each time.
STEP 03
Draw along the upper lash line only. Do not apply to the lower lid.
STEP 04
Blot excess. Repeat on the other eye with a fresh applicator.
REAL RESULTS
In a clinical study, 78% of patients saw a significant increase in overall eyelash prominence at week 16.

Baseline

Visibly fuller

Full results
Product details
REVIEWS
"By week 8 my mascara looked twice as long. By week 16 my friends started asking what extensions I was using."
Jenna R.
Verified member · 6 mo
"The whole process took maybe 15 minutes. The provider answered my questions about contacts thoughtfully."
Priya S.
Verified member · 4 mo
"Worth every penny. I've been on the bi-annual plan for a year and my lashes have never looked healthier."
Dana K.
Verified member · 1 yr
FAQ
Latisse is FDA-approved for treating inadequate eyelashes. Like all medications it can have side effects—including itching, redness, and rarely a darkening of the eyelid skin or iris. Your provider will review your history before prescribing.
Most people notice longer, fuller lashes by week 8. Full results are typically visible at week 16 with continued nightly use.
Yes—Latisse is a prescription medication. HerTeleMeds connects you with a U.S.-licensed provider who reviews your information online and prescribes if appropriate.
Remove contacts before applying Latisse and wait 15 minutes before reinserting. You can wear makeup as usual—just apply Latisse to clean, dry skin first.
Lashes will gradually return to their previous appearance over several weeks to months after stopping treatment.
Free, online consult. Free shipping. Cancel anytime.
LATISSE® (bimatoprost ophthalmic solution) 0.03% is indicated to treat hypotrichosis of the eyelashes by increasing their growth, including length, thickness, and darkness. LATISSE® is an FDA-approved prescription medication.
The most common adverse reactions, occurring in approximately 4% of patients, are eye pruritus, conjunctival hyperemia, skin hyperpigmentation, ocular irritation, dry eye symptoms, and erythema of the eyelid. Stop use and contact your provider if you experience eye redness, irritation, or any change in vision.
There are no adequate and well-controlled studies of LATISSE® administration in pregnant women. Caution should be exercised when LATISSE® is used during pregnancy or while nursing. Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding before starting LATISSE®.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. You may also contact us at support@hertelemeds.com.
LATISSE® is a registered trademark of Allergan, an AbbVie company. Please see the full FDA-approved Prescribing Information for LATISSE®, including BOXED WARNING and Medication Guide, available from the prescribing physician or at the manufacturer's website.